Johnson & Johnson has struck a deal with Sail Biomedicines, giving them an option to acquire the company for $2.58 billion.
2 reports, 1 independent
Updated Aug 29
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Johnson & Johnson has struck a deal with Sail Biomedicines, giving them an option to acquire the company for $2.58 billion.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Sail
Norwegian illustrator
Nothing else this week.